The Cisco-backed IT business management software producer has raised more than $135m in VC funding

The nitric-oxide skin therapeutics developer will use the proceeds to fund late-stage clinical trials for acne, skin infection and fungal infection treatments.

The nitric-oxide skin therapeutics developer will use the proceeds to fund late-stage clinical trials for acne, skin infection and fungal infection treatments.

The biotech company is seeking up to $45m from an initial public offering that will be conducted in April or May 2017, and is currently raising more funding.

The Foxconn and Sina Weibo-backed company, which develops apps that let users edit photos, is targeting up to $1bn in an offering on the Hong Kong stock exchange.

Johnson & Johnson, Eli Lilly and Pharmstandard exited the IBD treatment developer through an initial public offering that could eventually reach $103m in size.

The item tracking technology producer, which has also received funding from UPS and Unilever in the past, floated at the top of its range.

Alibaba and Legend Holdings have achieved exits as the chauffeured lift service, spun out of CAR 18 months ago, floated in China.

Alibaba and Legend Holdings are set to exit the chauffeured lift service, spun out of auto rental company CAR in early 2015, through a flotation in China.

Corporates Johnson & Johnson, Eli Lilly and Pharmstandard jointly hold more than 45% of the IBD drug developer, which has raised $67m since 2006.